PROTECTING YOUR RIGHT TO MEDICINES AND MEDICAL DEVICES
Thursday, 15 April 2021
Medicines Control Authority of Zimbabwe
Thursday, 15 April 2021

Medicines Control Authority of Zimbabwe

  • Download e-ADR Mobile and Desktop Apps

    The Authority wishes to notify stakeholders of the addition of several new methods of submitting Adverse Drug Reaction (ADR) reports, Serious Read More

  • Protecting Your Rights

    Medicines Control Authority of Zimbabwe is responsible for protecting public and animal health by ensuring that accessible medicines and allied substances and medical devices are safe, effective and of good quality through enforcement of adherence to standards by manufacturers and distributors Read More

  • MCAZ Chemistry

    The Chemistry Laboratory is capable of performing comprehensive analytical work on a wide range of medicinal substance, oral and injectable contraceptives using pharmacopoeial and validated in-house methods. Read More

  • Registration of Medicines

    The Medicines and Allied Substances Control Act (MASCA)[15:03] and the Medicines and Allied Substances Control Regulations (MASCR) SI 150 of 1991 requires that all medicines be registered, after scientific scrutiny of quality, safety and efficacy data, before they are allowed to be used on the Zimbabwean public and/or animals. Read More

  • MCAZ Medical Devices

    Medical devices unit carries out quality control testing of condoms and gloves in line with international standards. Physical tests are carried out on the medical devices as well as checks for poor workmanship. Read More
› ‹
  • 1
  • 2
  • 3
  • 4
  • 5

MCAZ Circulars

Customer Feedback

Quality Policy Statement

The Quality Policy of the Medicines Control Authority of Zimbabwe (MCAZ) is to ensure the provision of accurate and timeous services, continuously meet requirements of our customers and guarantee patient safety as stated in the Medicines and Allied Substances Control Act (Chapter 15:03). This enables the Authority to be an effective medicines regulator in Zimbabwe and a leading regulatory authority in the world. MCAZ is committed to protecting the public and animal health by ensuring that accessible medicines, allied substances and medical devices are safe, effective and of good quality. This is achieved by carrying out activities in accordance with the relevant procedures and specifications.

Click here to view Quality Policy Statement

 

Details
Last Updated: 03 April 2020
Hits: 3947

Get E-ADR Mobile Applications

 

MCAZ News

Covid-19 Vaccine Applications Submission Guidance

12 January 2021
Covid-19 Vaccine Applications Submission Guidance

Guidance on submission of covid-19 vaccine applications for emergency use authorisation and registration have been published. Click  MCAZ COVID-19 VACCINE GUIDANCE-VERSION 11 download the guideline.

Hits:523 Read More...

2019 Customer Complaints Trends Analysis

29 October 2020
2019 Customer Complaints Trends Analysis

  In order to improve service delivery to our valued customers, MCAZ collects information on Customer Complaints.   To download the 2019 Customer Complaints Trends Analysis Click here 

Hits:484 Read More...

MCAZ Covid-19 Health and Safety Guidelines

29 September 2020
MCAZ Covid-19 Health and Safety Guidelines

The Medicines Control Authority of Zimbabwe (MCAZ) Covid-19 Health and Safety Guidelines applies to MCAZ staff with the intention of preventing workplace infections, protecting lives, and promoting employee health for...

Hits:617 Read More...

Draft Medicines and Allied Substances Control (Blood and Blood Components) Regulations

26 June 2020
Draft Medicines and Allied Substances Control (Blood and Blood Components) Regulations

 The draft Blood and Blood Components Regulations are now available Please note that this is a DRAFT  that has been uploaded to obtain comments from stakeholders before the regulations are...

Hits:1026 Read More...

Medical Product Alert ; Falsified medical products, including in vitro diagnostics, that claim to prevent, detect, treat or cure COVID-19

06 April 2020
Medical Product Alert ; Falsified medical products, including in vitro diagnostics, that claim to prevent, detect, treat or cure COVID-19

  This Medical Product Alert warns consumers, healthcare professionals, and health authorities against a growing number of falsified medical products that claim to prevent, detect, treat orcure COVID-19.   Medical...

Hits:1399 Read More...

Draft SADC Variations Guidelines

20 March 2020

Draft SADC Variations Guidelines are now available  Click the following links to download the guidelines and the comments sheet Draft SADC Variations Guidelines Draft SADC Variations Guidelines Comments Sheet

Hits:1452 Read More...

Code of Ethics

22 August 2019
Code of Ethics

  In pursuit of promoting high ethical standards, the Authority has formulated a Code of Ethics for its employees and members of the Authority .The Authority believes that high ethical...

Hits:2959 Read More...

SADC Guideline on Product Information and Labeling

10 July 2019
SADC Guideline on Product Information and Labeling

  Southern African Development Community (SADC), as a region has harmonized medicines registration guidelines in the common technical document (CTD) format that were approved in January 2015. Nevertheless, the harmonization...

Hits:3321 Read More...

Medicines Information Bulletin - 2018

02 February 2018
Medicines Information Bulletin - 2018

Increased Reporting from the Targeted Spontaneous Reporting (TSR) Programme Click here to download the 2018 Drug Information Bulletin    

Hits:4574 Read More...

Quality Policy Statement

06 July 2018
Quality Policy Statement

The Quality Policy of the Medicines Control Authority of Zimbabwe (MCAZ) is to ensure the provision of accurate and timeous services, continuously meet requirements of our customers and guarantee patient...

Hits:3946 Read More...

Medicines Information Bulletin - 2019

20 December 2019
Medicines Information Bulletin - 2019

Inside this issue: E-Reporting Tools Safety Notifications for Fluoroquinolones and Quinolones Antibiotics Notification of a potential risk of non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma) in patients treated...

Hits:2016 Read More...

MCAZ Newsletter

Most Downloads

Copyright © 2016 Medicines Control Authority of Zimbabwe. All Rights Reserved.